Lupoid hepatitis: Difference between revisions
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Infobox_Disease | | {{Infobox_Disease | | ||
Name = {{PAGENAME}} | | Name = {{PAGENAME}} | | ||
| Line 9: | Line 10: | ||
OMIM = | | OMIM = | | ||
MedlinePlus = | | MedlinePlus = | | ||
MeshID = | | MeshID = | | ||
}} | }} | ||
| Line 16: | Line 15: | ||
{{CMG}} | {{CMG}} | ||
{{SK}} Autoimmune hepatitis | |||
==Overview== | ==Overview== | ||
'''Lupoid hepatitis''' (also called Autoimmune hepatitis) is an [[auto-immune disease]] which causes liver [[cirrhosis]]. It may be associated with [[systemic lupus erythematosus]] (SLE) or other [[connective tissue disorder]]s. 60% of patients have chronic [[hepatitis]] that may mimic viral hepatitis, but without [[serology|serologic]] evidence of a [[viral infection]]. The disease usually affects women and is strongly associated with anti-[[smooth muscle]] auto-[[antibody|antibodies]]. | '''Lupoid hepatitis''' (also called Autoimmune hepatitis) is an [[auto-immune disease]] which causes liver [[cirrhosis]]. It may be associated with [[systemic lupus erythematosus]] (SLE) or other [[connective tissue disorder]]s. 60% of patients have chronic [[hepatitis]] that may mimic viral hepatitis, but without [[serology|serologic]] evidence of a [[viral infection]]. The disease usually affects women and is strongly associated with anti-[[smooth muscle]] auto-[[antibody|antibodies]]. | ||
| Line 25: | Line 23: | ||
* Krawitt, E. L. 1996. Autoimmune hepatitis. New England Journal of Medicine. 334:897-903. | * Krawitt, E. L. 1996. Autoimmune hepatitis. New England Journal of Medicine. 334:897-903. | ||
[[Category:Hepatitis]] | [[Category:Hepatitis]] | ||
Latest revision as of 14:25, 2 November 2012
| Lupoid hepatitis | |
 | |
|---|---|
| Autoimmune hepatitis. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology |
|
WikiDoc Resources for Lupoid hepatitis |
|
Articles |
|---|
|
Most recent articles on Lupoid hepatitis Most cited articles on Lupoid hepatitis |
|
Media |
|
Powerpoint slides on Lupoid hepatitis |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Lupoid hepatitis at Clinical Trials.gov Trial results on Lupoid hepatitis Clinical Trials on Lupoid hepatitis at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Lupoid hepatitis NICE Guidance on Lupoid hepatitis
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Lupoid hepatitis Discussion groups on Lupoid hepatitis Patient Handouts on Lupoid hepatitis Directions to Hospitals Treating Lupoid hepatitis Risk calculators and risk factors for Lupoid hepatitis
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Lupoid hepatitis |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Autoimmune hepatitis
Overview
Lupoid hepatitis (also called Autoimmune hepatitis) is an auto-immune disease which causes liver cirrhosis. It may be associated with systemic lupus erythematosus (SLE) or other connective tissue disorders. 60% of patients have chronic hepatitis that may mimic viral hepatitis, but without serologic evidence of a viral infection. The disease usually affects women and is strongly associated with anti-smooth muscle auto-antibodies. Autoimmune hepatitis is a condition in which the patient's own immune systems attacks the liver causing inflammation and liver cell death. The condition is chronic and progressive. Although the disease is chronic, many patients with autoimmune hepatitis present acutely ill with jaundice, fever and sometimes symptoms of severe hepatic dysfunction, a picture that resembles acute hepatitis.
References
- Krawitt, E. L. 1996. Autoimmune hepatitis. New England Journal of Medicine. 334:897-903.